A nurse is caring for a client who has cirrhosis of the liver and is receiving spironolactone. Which of the following findings indicates that the client responding to the treatment?

A nurse is preparing to administer a medication to a client for the first time and needs to know about potential food and medication interactions. Which of the following actions should the nurse take?

A nurse is providing teaching to a client about how to self-administer subcutaneous injections of enoxaparin. Which of the following instructions should the nurse include?

A nurse is assessing a client who has septic shock and is receiving dopamine by continuous IV infusion. Which of the following findings indicates that the nurse should increase the rate of infusion?

A nurse is preparing to administer methotrexate in oral tablet form to a client. Which of the following actions should the nurse take?

A nurse is providing teaching to a client who has a new prescription for rifampin. Which of the following statements should the nurse include in the teaching?

A nurse is caring for a client who has major depressive disorder and a prescription for venlafaxine. For which of the following findings should the nurse notify the provider?

A nurse is reviewing the medication administration record for a client who has cancer and is receiving morphine via a PCA pump. Which of the following prescriptions should the nurse clarify with the provider?

A nurse is caring for a client in a clinic.

Complete the following sentence by using the lists of options.

Upon analyzing the assessment findings, the nurse identifies that the client is at risk for

A nurse is caring for a client who has a gonococcal infection and has been prescribed an IM injection of ceftriaxone. The client refuses the medication because they are afraid of needles. Which of the following responses should the nurse make?

A nurse is caring for a female client in an outpatient clinic.

Click to highlight the findings that require immediate follow-up. To deselect a finding, click on the finding again.

Nurses' Notes

Day 1:

Client is seen by provider for routine follow-up after being started on axcarbazepine 150mg PO twice a day, last week. Client reports no nausea, headache, dizziness, or ataxia. Provider increased oxcarbazepine to 300 mg PO twice a day. Client is to return for a follow-up in 2 weeks.

Day 14:

Client returns for follow-up after increasing oxcarbazepine dosage. Client reports starting to have mild headaches earlier this week. Also states, "Yesterday I was very nauseated and threw up before breakfast." When talking to client they have difficulty remembering the times they are taking their axcarbazepine. Client reports using oral contraceptives as the only means of birth control.

Laboratory Results

Day 14

Hct 40% (37% to 47%)

Hgb 13g/dL (12 to 16g/dL)

Sodium 124 mEq/L (136 to 145 mEq/L)

Vitals Signs

Day 14:

• Temperature 36.3°C (97.4° F)
• Heart rate 86/min